otherMolecular Weight: 1025.2

PT-141

Bremelanotide • Vyleesi

A synthetic peptide analog of α-MSH approved for treating sexual dysfunction.

Shop PT-141

Mechanism

Non-selective agonist of melanocortin receptors (MC1, MC3, MC4, MC5). Stimulates libido and sexual function.

Half-Life

2-3 hours

Administration

Subcutaneous,Intranasal

Technical Protocol

PT-141: Comprehensive Research Guide

Overview

PT-141 (Bremelanotide) is a synthetic peptide analog of α-MSH approved by the FDA for treating sexual dysfunction.

Mechanism of Action

Activates melanocortin receptors
Stimulates libido
Improves sexual function
Works centrally in the brain

This information is for research and educational purposes only.

Peer-Reviewed Citations

Bremelanotide for the treatment of hypoactive sexual desire disorder

Kingsberg SA, et al. • Obstet Gynecol (2019)

Access Research

Frequently Asked Questions

What is PT-141?

A synthetic peptide analog of α-MSH approved for treating sexual dysfunction.

How does PT-141 work?

Non-selective agonist of melanocortin receptors (MC1, MC3, MC4, MC5). Stimulates libido and sexual function.

What is the typical dosage of PT-141 in research?

The typical research dosage of PT-141 is 1.75 mg (range: 1-2 mg as needed). Common administration routes include Subcutaneous, Intranasal.

How should PT-141 be stored?

Store at 2-8°C, protect from light

Source PT-141 for Your Research

Third-party tested, EU-shipped, certificate of analysis included. High-purity PT-141 available from our verified research partner.